Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.23
+0.20 (2.49%)
At close: Apr 28, 2026, 4:00 PM EDT
8.23
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:00 PM EDT
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$825,444
Profits / Employee
$58,444
Market Cap
425.03M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Evolus | 334 |
| Esperion Therapeutics | 294 |
| Akebia Therapeutics | 194 |
| Aquestive Therapeutics | 147 |
| Ironwood Pharmaceuticals | 100 |
EBS News
- 11 hours ago - Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States - GlobeNewsWire
- 12 days ago - Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026 - GlobeNewsWire
- 12 days ago - Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility - GlobeNewsWire
- 19 days ago - Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program - GlobeNewsWire
- 21 days ago - Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness - GlobeNewsWire
- 26 days ago - Emergent BioSolutions Participates in Upcoming International Preparedness Conferences - GlobeNewsWire
- 4 weeks ago - Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures - GlobeNewsWire
- 6 weeks ago - Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look. - Barrons